The debate on MSCs, mesenchymal stromal cells versus mesenchymal stem cells, continued for more than two decades (since 2006), being the major obstacle for MSCs study and clinical application. The ...

Tencent Cloud, the cloud business of global leading technology company Tencent, has been named as a leader among cloud ...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection by Japan's ...

Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical ...

India currently holds a 2-3 per cent share of the USD 140-145 billion global CRDMO market but has the potential to become a ...

Road Transport Minister Nitin Gadkari announced the commencement of road projects worth Rs 80,000 crore in Assam, including ...

India’s Contract Research Development and Manufacturing Organisation (CRDMO) sector is at an inflection point, with ...

India's CRDMO sector is poised for significant growth, with potential to reach USD 25 billion by 2035, driven by de-risking ...

India is known as the ‘pharmacy of the world,’ dominating generic drug manufacturing. But now, the country is moving up the ...

Hyderabad: The Contract Research, Development, and Manufacturing Organisation (CRDMO) sector in India is at an inflection ...

BioAsia 2025 in Hyderabad sees major investments in Green Pharma City near the city, partnerships to boost Life Sciences ...

India’s CRDMO market, currently holding 2-3% of the global share, has the potential to reach $22-25 billion by 2035, says a ...